Immunogen Inc (DELISTED) (IMGN:DL)
31.23
0.00 (0.00%)
USD |
NASDAQ |
Feb 13, 16:00
Immunogen Total Long Term Debt (Quarterly): 72.11M for Sept. 30, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | 72.11M |
June 30, 2023 | 71.96M |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 1.10M |
March 31, 2021 | 2.096M |
December 31, 2020 | 2.093M |
September 30, 2020 | 2.089M |
June 30, 2020 | 2.085M |
March 31, 2020 | 2.082M |
December 31, 2019 | 2.078M |
September 30, 2019 | 2.075M |
June 30, 2019 | 2.071M |
March 31, 2019 | 2.068M |
December 31, 2018 | 2.064M |
September 30, 2018 | 2.06M |
June 30, 2018 | 2.057M |
March 31, 2018 | 2.053M |
December 31, 2017 | 2.05M |
September 30, 2017 | 3.022M |
Date | Value |
---|---|
June 30, 2017 | 97.30M |
March 31, 2017 | 97.13M |
September 30, 2016 | 96.79M |
June 30, 2016 | 96.63M |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.00 |
September 30, 2011 | 0.00 |
June 30, 2011 | 0.00 |
March 31, 2011 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Sep 2021
72.11M
Maximum
Sep 2023
8.991M
Average
2.073M
Median
Total Long Term Debt (Quarterly) Benchmarks
AbbVie Inc | 74.00B |
Pfizer Inc | 68.71B |
Johnson & Johnson | 33.63B |
Merck & Co Inc | 34.22B |
Cerevel Therapeutics Holdings Inc | -- |